| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 17, 2017Virtual Press Office and PR Newswire: General Trade show news
Results from a Phase 2 randomized, multi-center clinical trial in pancreas cancer patients conducted by Halozyme Therapeutics (NASDAQ: HALO) of its targeted investigational therapy, PEGPH20, will...
-
May 17, 2017Virtual Press Office and PR Newswire: General Trade show news
Bayer announced today that the latest research from across its growing oncology portfolio will be presented at the 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO), taking place
-
May 17, 2017Virtual Press Office and PR Newswire: General Trade show news
CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced the presentation of two abstracts at the 2017 American Society of...
-
May 17, 2017Virtual Press Office and PR Newswire: General Trade show news
Blueprint Medicines Corporation (NASDAQ: BPMC), a leader in discovering and development targeted kinase medicines for patients with genomically defined diseases, today announced that new data from...
-
May 17, 2017Virtual Press Office and PR Newswire: General Trade show news
Eli Lilly and Company (NYSE: LLY) today announced that new research demonstrating advances in the Company's oncology pipeline and product portfolio will be presented at the 53rd Annual Meeting of...
